These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 23274410

  • 1. Icariin potentiates the antitumor activity of gemcitabine in gallbladder cancer by suppressing NF-κB.
    Zhang DC, Liu JL, Ding YB, Xia JG, Chen GY.
    Acta Pharmacol Sin; 2013 Feb; 34(2):301-8. PubMed ID: 23274410
    [Abstract] [Full Text] [Related]

  • 2. Maslinic acid potentiates the antitumor activities of gemcitabine in vitro and in vivo by inhibiting NF-κB-mediated survival signaling pathways in human gallbladder cancer cells.
    Yu Y, Wang J, Xia N, Li B, Jiang X.
    Oncol Rep; 2015 Apr; 33(4):1683-90. PubMed ID: 25633045
    [Abstract] [Full Text] [Related]

  • 3. Combination chemotherapy of nafamostat mesylate with gemcitabine for gallbladder cancer targeting nuclear factor-κB activation.
    Iwase R, Haruki K, Fujiwara Y, Furukawa K, Shiba H, Uwagawa T, Misawa T, Ohashi T, Yanaga K.
    J Surg Res; 2013 Sep; 184(1):605-12. PubMed ID: 23830367
    [Abstract] [Full Text] [Related]

  • 4. Guggulsterone enhances antitumor activity of gemcitabine in gallbladder cancer cells through suppression of NF-κB.
    Yang MH, Lee KT, Yang S, Lee JK, Lee KH, Moon IH, Rhee JC.
    J Cancer Res Clin Oncol; 2012 Oct; 138(10):1743-51. PubMed ID: 22699931
    [Abstract] [Full Text] [Related]

  • 5. Nafamostat mesilate, a nuclear factor kappa B inhibitor, enhances the antitumor action of radiotherapy on gallbladder cancer cells.
    Takada N, Sugano H, Shirai Y, Saito N, Hamura R, Taniai T, Uwagawa T, Yanaga K, Ikegami T, Ohashi T, Eto K.
    PLoS One; 2021 Oct; 16(9):e0257019. PubMed ID: 34473771
    [Abstract] [Full Text] [Related]

  • 6. α-Mangostin suppresses the de novo lipogenesis and enhances the chemotherapeutic response to gemcitabine in gallbladder carcinoma cells via targeting the AMPK/SREBP1 cascades.
    Shi Y, Fan Y, Hu Y, Jing J, Wang C, Wu Y, Geng Q, Dong X, Li E, Dong D.
    J Cell Mol Med; 2020 Jan; 24(1):760-771. PubMed ID: 31762191
    [Abstract] [Full Text] [Related]

  • 7. Emodin potentiates the antitumor effects of gemcitabine in pancreatic cancer cells via inhibition of nuclear factor-κB.
    Liu A, Chen H, Tong H, Ye S, Qiu M, Wang Z, Tan W, Liu J, Lin S.
    Mol Med Rep; 2011 Jan; 4(2):221-7. PubMed ID: 21468555
    [Abstract] [Full Text] [Related]

  • 8. Icariin-mediated inhibition of NF-κB activity enhances the in vitro and in vivo antitumour effect of 5-fluorouracil in colorectal cancer.
    Shi DB, Li XX, Zheng HT, Li DW, Cai GX, Peng JJ, Gu WL, Guan ZQ, Xu Y, Cai SJ.
    Cell Biochem Biophys; 2014 Jul; 69(3):523-30. PubMed ID: 24435883
    [Abstract] [Full Text] [Related]

  • 9. Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products.
    Kunnumakkara AB, Guha S, Krishnan S, Diagaradjane P, Gelovani J, Aggarwal BB.
    Cancer Res; 2007 Apr 15; 67(8):3853-61. PubMed ID: 17440100
    [Abstract] [Full Text] [Related]

  • 10. Phenoxodiol enhances the antitumor activity of gemcitabine in gallbladder cancer through suppressing Akt/mTOR pathway.
    Li Y, Huang X, Huang Z, Feng J.
    Cell Biochem Biophys; 2014 Nov 15; 70(2):1337-42. PubMed ID: 24902539
    [Abstract] [Full Text] [Related]

  • 11. Icariin synergizes with arsenic trioxide to suppress human hepatocellular carcinoma.
    Li W, Wang M, Wang L, Ji S, Zhang J, Zhang C.
    Cell Biochem Biophys; 2014 Mar 15; 68(2):427-36. PubMed ID: 23975599
    [Abstract] [Full Text] [Related]

  • 12. Coix seed emulsion synergistically enhances the antitumor activity of gemcitabine in pancreatic cancer through abrogation of NF-κB signaling.
    Qian Y, Yang B, Xiong Y, Gu M.
    Oncol Rep; 2016 Sep 15; 36(3):1517-25. PubMed ID: 27459907
    [Abstract] [Full Text] [Related]

  • 13. HDAC6 inhibitor, ACY1215 suppress the proliferation and induce apoptosis of gallbladder cancer cells and increased the chemotherapy effect of gemcitabine and oxaliplatin.
    Ruan Y, Wang L, Lu Y.
    Drug Dev Res; 2021 Jun 15; 82(4):598-604. PubMed ID: 33428788
    [Abstract] [Full Text] [Related]

  • 14. S-adenosylmethionine induces apoptosis and cycle arrest of gallbladder carcinoma cells by suppression of JAK2/STAT3 pathways.
    Liu Y, Bi T, Yuan F, Gao X, Jia G, Tian Z.
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Dec 15; 393(12):2507-2515. PubMed ID: 32219484
    [Abstract] [Full Text] [Related]

  • 15. Proteasome inhibition sensitizes non-small-cell lung cancer to gemcitabine-induced apoptosis.
    Denlinger CE, Rundall BK, Keller MD, Jones DR.
    Ann Thorac Surg; 2004 Oct 15; 78(4):1207-14; discussion 1207-14. PubMed ID: 15464472
    [Abstract] [Full Text] [Related]

  • 16. Induction of caspase mediated apoptosis and down-regulation of nuclear factor-κB and Akt signaling are involved in the synergistic antitumor effect of gemcitabine and the histone deacetylase inhibitor trichostatin A in human bladder cancer cells.
    Jeon HG, Yoon CY, Yu JH, Park MJ, Lee JE, Jeong SJ, Hong SK, Byun SS, Lee SE.
    J Urol; 2011 Nov 15; 186(5):2084-93. PubMed ID: 21944112
    [Abstract] [Full Text] [Related]

  • 17. Antitumor activity of gemcitabine can be potentiated in pancreatic cancer through modulation of TLR4/NF-κB signaling by 6-shogaol.
    Zhou L, Qi L, Jiang L, Zhou P, Ma J, Xu X, Li P.
    AAPS J; 2014 Mar 15; 16(2):246-57. PubMed ID: 24424498
    [Abstract] [Full Text] [Related]

  • 18. New treatment strategy with nuclear factor-κB inhibitor for pancreatic cancer.
    Horiuchi T, Uwagawa T, Shirai Y, Saito N, Iwase R, Haruki K, Shiba H, Ohashi T, Yanaga K.
    J Surg Res; 2016 Nov 15; 206(1):1-8. PubMed ID: 27916347
    [Abstract] [Full Text] [Related]

  • 19. Piperlongumine Suppresses Growth and Sensitizes Pancreatic Tumors to Gemcitabine in a Xenograft Mouse Model by Modulating the NF-kappa B Pathway.
    Wang Y, Wu X, Zhou Y, Jiang H, Pan S, Sun B.
    Cancer Prev Res (Phila); 2016 Mar 15; 9(3):234-44. PubMed ID: 26667450
    [Abstract] [Full Text] [Related]

  • 20. Synergistic Anti-Cancer Effects of Icariin and Temozolomide in Glioblastoma.
    Yang L, Wang Y, Guo H, Guo M.
    Cell Biochem Biophys; 2015 Apr 15; 71(3):1379-85. PubMed ID: 25384619
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.